journal article·2015-09

Evaluation of nanostructure and microstructure of bone regenerated by BMP‐2‐porous scaffolds

Carlos Del Rosario, Maria Rodríguez‐Evora, Ricardo Reyes, Alejandro González‐Orive, Alberto Hernández‐Creus, Kevin M Shakesheff, Lisa J White, Araceli Delgado, Carmen Evora

Publisher page

Abstract

Abstract In this study, three systems containing BMP‐2 were fabricated, including two electrospun sandwich‐like‐systems of PLGA 75:25 and PLGA 50:50 and a microsphere system of PLGA 50:50 to be implanted in a critical size defect in rat calvaria. The in vivo BMP‐2 release profiles of the three systems were similar. The total dose was released during the first two weeks. To evaluate the nano and microstructure of the regenerated bone a multi‐technique analysis was used, including stereo microscope, X‐Ray; AFM, micro‐CT, and histological analyses. The progression of bone regeneration was followed at 4, 8, and 12 weeks after the microsphere system implantation whereas the two electrospun systems were evaluated at fixed 12 weeks. All the techniques applied showed high bone regeneration. The average values of bone volume density, bone mineral density, Young's modulus, and the percent of bone repair were ∼70% of the values of the native bone. Besides, SEM‐EDX analysis indicated that the main chemical elements in the new bone were oxygen, calcium, and phosphorus in a ratio similar to that of native bone. In comparison, the micro‐CT may provide an alternative to histology for the evaluation of bone formation at the defect size. © 2015 Wiley Periodicals, Inc. J Biomed Mater Res Part A: 103A: 2998–3011, 2015.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Bone Tissue Engineering Materials · Polymer Surface Interaction Studies · Calcium Carbonate Crystallization and Inhibition

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Chemical Engineering and Pharmaceutical Technology University of La Laguna 38200 Spain

Institute of Biomedical Technologies (ITB), Center for Biomedical Research of the Canary Islands, University of La Laguna 38200 Spain

Department of Physico‐Chemistry Institute of Materials and Nanotechnology, University of La Laguna 38200 Spain

Wolfson Centre for Stem Cells Tissue Engineering and Modelling (STEM) School of Pharmacy University of Nottingham United Kingdom

Funding

Ministry of Science and Technology

References (38)

Show source-provided references
1. 10.1021/la300811m10.1021/la300811m ↗
2. 10.1038/nmeth.260210.1038/nmeth.2602 ↗
3. 10.1016/j.bone.2011.11.00810.1016/j.bone.2011.11.008 ↗
4. 10.1023/A:101407942189510.1023/A:1014079421895 ↗
5. 10.1016/j.compscitech.2005.10.00510.1016/j.compscitech.2005.10.005 ↗
6. 10.1016/j.bone.2004.02.02410.1016/j.bone.2004.02.024 ↗
7. 10.1088/0957-4484/18/13/13510210.1088/0957-4484/18/13/135102 ↗
8. 10.1016/j.actbio.2011.05.02810.1016/j.actbio.2011.05.028 ↗
9. 10.1016/j.exger.2011.11.01110.1016/j.exger.2011.11.011 ↗
10. 10.1017/S143192761300176110.1017/S1431927613001761 ↗
11. 10.1016/j.exger.2014.03.00110.1016/j.exger.2014.03.001 ↗
12. 10.1529/biophysj.104.05522810.1529/biophysj.104.055228 ↗
13. 10.1007/s10856-005-4429-910.1007/s10856-005-4429-9 ↗
14. 10.1038/nmat191110.1038/nmat1911 ↗
15. 10.1080/10255842.2013.81597410.1080/10255842.2013.815974 ↗
16. 10.1016/j.apsusc.2005.03.09710.1016/j.apsusc.2005.03.097 ↗
17. 10.1016/j.jbiomech.2005.12.01210.1016/j.jbiomech.2005.12.012 ↗
18. 10.1089/ten.tea.2007.024110.1089/ten.tea.2007.0241 ↗
19. 10.1371/journal.pone.009848010.1371/journal.pone.0098480 ↗
20. Bone formation in a rat tibial defect model using carboxymethyl cellulose/BioC/bone morphogenic protein‐2 hybrid materials
21. Using poly(lactic‐co‐glycolic acid) microspheres to encapsulate plasmid of bone morphogenetic protein 2/polyethylenimine nanoparticles to promote bone formation in vitro and in vivo
22. 10.1021/bm401911p10.1021/bm401911p ↗
23. 10.1016/j.actbio.2011.10.00810.1016/j.actbio.2011.10.008 ↗
24. 10.1021/bm401854d10.1021/bm401854d ↗
25. 10.1016/0006-291X(78)91322-010.1016/0006-291X(78)91322-0 ↗
26. 10.1016/j.ejpb.2009.04.01410.1016/j.ejpb.2009.04.014 ↗
27. 10.1016/j.actbio.2012.08.02910.1016/j.actbio.2012.08.029 ↗
28. 10.1016/j.ejps.2013.06.00810.1016/j.ejps.2013.06.008 ↗
29. 10.1038/nprot.2012.11310.1038/nprot.2012.113 ↗
30. 10.1016/j.jconrel.2006.05.02610.1016/j.jconrel.2006.05.026 ↗
31. Mathematical comparison of dissolution profiles
32. CDER (U.S. Department of Health and Human Services Food and Drug Administration Center for Drug Evaluation and Research). Guidance for Industry.Waiver of In Vivo Bioavailability and Bioequivalence Studies for Bioequivalence Studies for Immediate‐Release Solid Oral Dosage Forms Based on a Biopharmaceutics Classification System. August2000.www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM070246.pdf
33. 10.1021/am301439k10.1021/am301439k ↗
34. 10.1088/0957-4484/13/1/30710.1088/0957-4484/13/1/307 ↗
35. 10.1016/0020-7225(65)90019-410.1016/0020-7225(65)90019-4 ↗
36. 10.1016/j.surfrep.2005.08.00310.1016/j.surfrep.2005.08.003 ↗
37. 10.1063/1.243241010.1063/1.2432410 ↗
38. 10.1016/j.jconrel.2011.02.00310.1016/j.jconrel.2011.02.003 ↗